14 results
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
Guidelines for Management ... of Giant Cell Arteritis ... (GCA) #GiantCell ... #Arteritis #GCA ... #rheumatology #
Giant Cell (Temporal) Arteritis

Dr. Ann Marie Kumfer @AnnKumfer

#GiantCell #Temporal #Arteritis #Diagnosis #Management #GCA #rheumatology
Giant Cell (Temporal ... @AnnKumfer #GiantCell ... Arteritis #Diagnosis #Management ... #GCA #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Giant Cell Arteritis ... Management Algorithm ... @MithuRheum #GiantCell ... #Vasculitis #Management ... Guidelines #algorithm #rheumatology
Suggested Treatment Algorithms for the Management of Polymyalgia Rheumatica and Giant Cell Arteritis

#Management #Algorithm #GCA #PMR
Algorithms for the Management ... Rheumatica and Giant ... Cell Arteritis #Management ... #Algorithm #GCA ... Polymyalgia #Rheumatica #GiantCell
Treatment of giant cell arteritis (GCA)

1st Line Strategy - GC 0.7 mg/kg/day, except for:
 • Aortitis
Treatment of giant ... TerrierBen #giantcell ... #Treatment #Management ... #Relapses #Indications ... #rheumatology #2ndline
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... • Giant Cell Arteritis ... (GCA) • Takayasu's ... Sources: GCA ... Guidelines #algorithm #rheumatology
Giant Cell (Temporal) Arteritis: Pathogenesis and investigations
Risk Factors:
 - Unclear environmental triggers (may be viral, not
Giant Cell (Temporal ... expression - Age: GCA ... - Normocytic Anemia ... - Giant cells ... neurological findings #GiantCell
Giant cell arteritis (GCA)

Giant cell arteritis (GCA) definition: Most common systemic inflammatory vasculitis in older adults
(GCA) Giant cell ... systemic complaints- anemia ... them, but urgent rheumatology ... #GiantCell #arteritis ... Symptoms #Diagnosis #Management
IgG4-Related Disease
Clinical history:  Man, 60 years, multiorgan involvement, unique or multiple inflammatory pseudotumor
4 phenotypes:
 •
, lacrimal gland ... maintenance with GCs ... GC-dependency ... Disease #diagnosis #management ... workup #treatment #rheumatology
JAK Inhibitors in 2019

Role in the therapeutic strategy in 2019
 • RA: 2nd line after failure
failure of 5-ASA, GCs ... JAKInhibitors #Indications ... #Rheumatology # ... Management